Cargando…
Published trials of TACE for HCC are often not registered and subject to outcome reporting bias
BACKGROUND & AIMS: In 2005, the registration of all randomised controlled trials (RCTs) before enrolment of participants became a condition for publication by the International Committee of Medical Journal Editors to increase transparency in trial reporting. Among RCTs on transarterial chemoembo...
Autores principales: | Grégory, Jules, Créquit, Perrine, Vilgrain, Valérie, Boutron, Isabelle, Ronot, Maxime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804986/ https://www.ncbi.nlm.nih.gov/pubmed/33490934 http://dx.doi.org/10.1016/j.jhepr.2020.100196 |
Ejemplares similares
-
Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response
por: Dioguardi Burgio, Marco, et al.
Publicado: (2019) -
Evaluation of liver tumour response by imaging
por: Gregory, Jules, et al.
Publicado: (2020) -
Reporting of harms in oncological clinical study reports submitted to the European Medicines Agency compared to trial registries and publications—a methodological review
por: Paludan-Müller, Asger S., et al.
Publicado: (2021) -
2D-shear wave elastography: number of acquisitions can be reduced according to clinical setting
por: Dioguardi Burgio, Marco, et al.
Publicado: (2021) -
Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
por: Lucatelli, Pierleone, et al.
Publicado: (2021)